169 related articles for article (PubMed ID: 32053347)
1. Dimethylaminophenyl Hydrazides as Inhibitors of the Lipid Transport Protein LprG in Mycobacteria.
Bai L; Parkin LA; Zhang H; Shum R; Previti ML; Seeliger JC
ACS Infect Dis; 2020 Apr; 6(4):637-648. PubMed ID: 32053347
[TBL] [Abstract][Full Text] [Related]
2. A Screen for Protein-Protein Interactions in Live Mycobacteria Reveals a Functional Link between the Virulence-Associated Lipid Transporter LprG and the Mycolyltransferase Antigen 85A.
Touchette MH; Van Vlack ER; Bai L; Kim J; Cognetta AB; Previti ML; Backus KM; Martin DW; Cravatt BF; Seeliger JC
ACS Infect Dis; 2017 May; 3(5):336-348. PubMed ID: 28276676
[TBL] [Abstract][Full Text] [Related]
3. A Loss of Function in LprG-Rv1410c Homologues Attenuates Growth during Biofilm Formation in
Nisbett LM; Previti ML; Seeliger JC
Pathogens; 2023 Nov; 12(12):. PubMed ID: 38133260
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterium tuberculosis lipoprotein LprG (Rv1411c) binds triacylated glycolipid agonists of Toll-like receptor 2.
Drage MG; Tsai HC; Pecora ND; Cheng TY; Arida AR; Shukla S; Rojas RE; Seshadri C; Moody DB; Boom WH; Sacchettini JC; Harding CV
Nat Struct Mol Biol; 2010 Sep; 17(9):1088-95. PubMed ID: 20694006
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterial Metabolic Syndrome: LprG and Rv1410 Regulate Triacylglyceride Levels, Growth Rate and Virulence in Mycobacterium tuberculosis.
Martinot AJ; Farrow M; Bai L; Layre E; Cheng TY; Tsai JH; Iqbal J; Annand JW; Sullivan ZA; Hussain MM; Sacchettini J; Moody DB; Seeliger JC; Rubin EJ
PLoS Pathog; 2016 Jan; 12(1):e1005351. PubMed ID: 26751071
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a Mycobacterium avium subsp. avium operon associated with virulence and drug detoxification.
Viale MN; Park KT; Imperiale B; Gioffre AK; Colombatti Olivieri MA; Moyano RD; Morcillo N; Santangelo Mde L; Davis W; Romano MI
Biomed Res Int; 2014; 2014():809585. PubMed ID: 24967408
[TBL] [Abstract][Full Text] [Related]
7. LprG-mediated surface expression of lipoarabinomannan is essential for virulence of Mycobacterium tuberculosis.
Gaur RL; Ren K; Blumenthal A; Bhamidi S; González-Nilo FD; Jackson M; Zare RN; Ehrt S; Ernst JD; Banaei N
PLoS Pathog; 2014 Sep; 10(9):e1004376. PubMed ID: 25232742
[TBL] [Abstract][Full Text] [Related]
8. Mycobacterium tuberculosis lipoprotein LprG binds lipoarabinomannan and determines its cell envelope localization to control phagolysosomal fusion.
Shukla S; Richardson ET; Athman JJ; Shi L; Wearsch PA; McDonald D; Banaei N; Boom WH; Jackson M; Harding CV
PLoS Pathog; 2014 Oct; 10(10):e1004471. PubMed ID: 25356793
[TBL] [Abstract][Full Text] [Related]
9. Multiple Mutations in Mycobacterium tuberculosis MmpL3 Increase Resistance to MmpL3 Inhibitors.
McNeil MB; O'Malley T; Dennison D; Shelton CD; Sunde B; Parish T
mSphere; 2020 Oct; 5(5):. PubMed ID: 33055263
[TBL] [Abstract][Full Text] [Related]
10. Function of a mycobacterial major facilitator superfamily pump requires a membrane-associated lipoprotein.
Farrow MF; Rubin EJ
J Bacteriol; 2008 Mar; 190(5):1783-91. PubMed ID: 18156250
[TBL] [Abstract][Full Text] [Related]
11. Lipid transport in Mycobacterium tuberculosis and its implications in virulence and drug development.
Bailo R; Bhatt A; Aínsa JA
Biochem Pharmacol; 2015 Aug; 96(3):159-67. PubMed ID: 25986884
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for triacylglyceride extraction from mycobacterial inner membrane by MFS transporter Rv1410.
Remm S; De Vecchis D; Schöppe J; Hutter CAJ; Gonda I; Hohl M; Newstead S; Schäfer LV; Seeger MA
Nat Commun; 2023 Oct; 14(1):6449. PubMed ID: 37833269
[TBL] [Abstract][Full Text] [Related]
13. Effect of the deletion of lprG and p55 genes in the K10 strain of Mycobacterium avium subspecies paratuberculosis.
Viale MN; Colombatti Olivieri MA; Alonso N; Moyano RD; Imperiale B; Morcillo N; Santangelo MP; Davis W; Romano MI
Res Vet Sci; 2021 Sep; 138():1-10. PubMed ID: 34087563
[TBL] [Abstract][Full Text] [Related]
14. The knockout of the lprG-Rv1410 operon produces strong attenuation of Mycobacterium tuberculosis.
Bigi F; Gioffré A; Klepp L; Santangelo MP; Alito A; Caimi K; Meikle V; Zumárraga M; Taboga O; Romano MI; Cataldi A
Microbes Infect; 2004 Feb; 6(2):182-7. PubMed ID: 14998516
[TBL] [Abstract][Full Text] [Related]
15. Mycobacterium tuberculosis glycolipoprotein LprG inhibits inflammation through NF-κB signaling of ERK1/2 and JNK in LPS-induced murine macrophage cells.
Abekura F; Park J; Lim H; Kim HD; Choi H; Lee MJ; Kim CH
J Cell Biochem; 2022 Apr; 123(4):772-781. PubMed ID: 35060178
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Mycobacterium tuberculosis transaminase BioA by aryl hydrazines and hydrazides.
Dai R; Wilson DJ; Geders TW; Aldrich CC; Finzel BC
Chembiochem; 2014 Mar; 15(4):575-86. PubMed ID: 24482078
[TBL] [Abstract][Full Text] [Related]
17. Induced Mutation Proves a Potential Target for TB Therapy: A Molecular Dynamics Study on LprG.
Machaba KE; Mhlongo NN; Soliman MES
Cell Biochem Biophys; 2018 Sep; 76(3):345-356. PubMed ID: 30073572
[TBL] [Abstract][Full Text] [Related]
18. Trehalose Recycling Promotes Energy-Efficient Biosynthesis of the Mycobacterial Cell Envelope.
Pohane AA; Carr CR; Garhyan J; Swarts BM; Siegrist MS
mBio; 2021 Jan; 12(1):. PubMed ID: 33468692
[TBL] [Abstract][Full Text] [Related]
19. Cyclipostins and cyclophostin analogs inhibit the antigen 85C from
Viljoen A; Richard M; Nguyen PC; Fourquet P; Camoin L; Paudal RR; Gnawali GR; Spilling CD; Cavalier JF; Canaan S; Blaise M; Kremer L
J Biol Chem; 2018 Feb; 293(8):2755-2769. PubMed ID: 29301937
[TBL] [Abstract][Full Text] [Related]
20. Increased drug permeability of a stiffened mycobacterial outer membrane in cells lacking MFS transporter Rv1410 and lipoprotein LprG.
Hohl M; Remm S; Eskandarian HA; Dal Molin M; Arnold FM; Hürlimann LM; Krügel A; Fantner GE; Sander P; Seeger MA
Mol Microbiol; 2019 May; 111(5):1263-1282. PubMed ID: 30742339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
